FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences Venture Capital Monitor – Europe 04/2021”. The Monitor is a monthly published overview of venture capital trends in the European Life … Read more
Is the boom around Special Purpose Acquisition Companies (SPAC) currently suffering a cool off? The number of SPAC IPOs as well as the number of new SPACs in the IPO pipeline have significantly declined since … Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Life Sciences SPAC Monitor – 05/2021”. The Monitor is a quarterly published overview focusing on the performance of life sciences companies after the … Read more
Number of SPAC IPOs has stagnated since April Potential reason could be a Statement from U.S. Securities and Exchange Commission (SEC) 611 SPAC IPOs since May 2020 Munich, May 18, 2021 – The boom around … Read more
The Top 10 biotech M&A deals ranking (by ticket size) shows that there have been exceptionally large deals in the biotech sector over the last years. The largest deal was the acquisition of Celgene by Bristol … Read more
As expected, the top US Series A rounds in Biotech substantially outperformed the top European rounds. In 2020, the average ticket size of the top 10 Series A deals in Biotech (by ticket size) in … Read more
Financing volume in the USA doubled in the first quarter of 2021 High growth also in Europe Munich, May 05, 2021 – The boom in biotech venture capital financing continues: In the US, the venture … Read more
This week we report an exceptional increase in U.S. Biotech venture capital funding. Compared to the 1st quarter of last year, accumulated biotech venture capital funding in the United States has increased by staggering 106%, reaching … Read more
FCF Fox Corporate Finance GmbH is delighted to publish the new “FCF Biotech Venture Capital Monitor – USA 04/2021”. The Monitor is a monthly published overview of venture capital trends in the US-Biotech sector. As … Read more
Venture capital funding in the European Life Sciences industry in the 1st quarter of 2021 remains unaffected by the negative impact of the COVID-19 pandemic. Compared to the 1st quarter of the previous year, accumulated … Read more
